Cladribine treatment outcomes of hairy cell leukemia Hairy cell lösemi olgularimizda cladribine tedavi sonuçlari


Altintaş A., Ayyildiz O., ATAY A. E., ÇİL T., Müftüoǧlu E.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.16, sa.2, ss.67-70, 2006 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 2
  • Basım Tarihi: 2006
  • Dergi Adı: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.67-70
  • Anahtar Kelimeler: Cladribine, Hairy cell leukemia
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Hairy cell leukemia is a rare, clonal, chronic B cell lenfoproliferative disease characterized by splenomegaly and pancytopenia. Purine analogues are first-line choice of therapy. Although effectivity of treatment is established, relapses may occur. In this state, remission may achieved by a new cycle of 2-CdA or alternative modalities. In this report, we represented the results of our patients with HCL that were treated with 2-CdA and followed up in our center.